Nucleic Acid Amplification, Novel Influenza A Virus, A/h5 (asian Lineage) Rna
Microbiology · 21 CFR 866.3332
Novel influenza a virus reagents are used in nucleic acid amplification tests to directly detect and differentiate novel influenza a virus specific rna gene segments in human respiratory specimens or viral cultures. Detection and differentiation of specific rna gene segments aids in the diagnosis of influenza caused by novel influenza a viruses in patients with clinical and epidemiological risk of infection with these viruses. They also aid in the presumptive identification of specific novel influenza a viruses and provide epidemiological information on influenza. These reagents are primers and probes, along with a specific novel influenza virus control.
Recent MDR events
0 adverse event reports on file
No MDR events on file for this product code.
Event type breakdown
No data available.
Most-reported manufacturers
No data available.
Recalls
0 recall events for this product code
No recalls on file for this product code.
Registered firms
1 firms currently registered for this product code
510(k) clearances
3 clearances for this product code
- U.S. Army Medical Material Development CommandJul 6, 2010
K100287 · JBAIDS INFLUENZA A/H5 DETECTION KIT, MODEL JRPD-ASY-0136
- Centers for Disease Control and PreventionSep 30, 2008
K080570 · CDC HUMAN INFLUENZA VIRUS REAL-TIME RT- PCR DETECTION AND CHARACTERIZATION PANEL
- Centers for Disease Control and PreventionFeb 3, 2006
DEN060008 · INFLUENZA A/H5 (ASIAN LINEAGE) VIRUS REAL-TIME RT-PCR PRIMER AND PROBE SET